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Dystrophic epidermolysis bullosa is characterized by various 
abnormalities of anchoring fibrils, which are mainly com-
posed of type VII collagen, at the dermal-epidermal junction. 
To define these changes more clearly, we examined skin 
samples from 22 patients with different forms of dystrophic 
epidermolysis bullosa by pre-embedding immunoelectron 
microscopy using an antibody (LH 7:2) that binds to the 
NC-l globular domain of type VII collagen, followed by 
1 nm colloidal gold-labeled secondary antibodies and subse-
quent silver enhancement. In dominant dystrophic epider-
molysis bullosa cases, there was only a slight but variable 
reduction in the immunolabeling density on anchoring fi -
brils and on the lamina densa, in parts similar to normal 
human skin. In localized recessive dystrophic epidermolysis 
bullosa skin, some fibrillar structures just below the lamina 
densa (and particularly subjacent to hemidesmosomes) had 
specific antibody labeling despite their lack of resemblance to 
definitive anchoring fibrils. Immunolabeling with LH 7:2 
D ystrophic epidermolysis bullosa (DEB) encompasses a group of inherited disorders associated with trauma-induced mucocutaneous blistering and scar-ring. Ultrastructurally, DEB is characterized by qualitative or quantitative changes in anchoring fi-
brils (AFs) at the dermal-epidermal junction and a sub-lamina densa 
level of blister formation [1-8]. The principal DEB subtypes in-
clude dominant, localized recessive and generalized recessive forms 
of the condition, [9] although a recently updated EB classification 
documents at least 10 possible DEB subtypes [10]. The different 
types of DEB are distinguished both on clinical and laboratory cri-
teria, using electron microscopy [5] and indirect immunofluores-
cence labeling of the basement membrane zone with antibodies to 
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was also seen within basal keratinocyte endoplasmic reticu-
lum and cytoplasmic vesicles in some dystrophic epidermo-
lysis bullosa patients, usually with milder phenotypic fea-
tures. Even in the most severe cases of generalized recessive 
dystrophic epidermolysis bullosa, occasional immunolabel-
ing was found within the lamina densa and on scanty thin 
filamentous structures at sub-lamina densa sites usually occu-
pied by anchoring fibrils . This study suggests that dystrophic 
epidermolysis bullosa patients express some type VII collagen 
NC-l domain epitopes that may be variably reduced at the 
dermal-epidermal junction or retained within basal keratino-
cytes. The clinical heterogeneity in dystrophic epidermolysis 
bullosa is mirrored by a range of immunoelectron microscopy 
findings, indicating variability in completeness of anchoring 
fibril formation and a possible spectrum of underlying type 
VII collagen structural protein abnormalities.] Invest Derma-
toI100:366-372,1993 
type VII collagen (VII c) [11-14], the major structural component 
of AFs [15 -17]. Electron microscopy in dominant DEB and in some 
cases of localized recessive DEB may show AFs similar to normal 
skin with fanning, central cross-banding, and insertion into the 
lamina densa [5,18], although the overall number of AFs is reduced 
or absent. In many cases of DEB, however, and especially in general-
ized recessive DEB, AFs may be completely lacking, and only thin 
"wispy" fibrillar structures of uncertain origin and composition are 
seen just below the lamina densa. Immunofluorescence studies with 
anti-type VIlc antibodies may also show a range of labeling patterns 
frolp normal or near-normal dermal-epidermal junction fluores-
cence in dominant DEB to absent labeling in severe generalized 
recessive DEB. Despite the use of both these techniques, there may 
be considerable overlap between many cases of DEB, particularly 
between some cases of dominant DEB and mild localized recessive 
DEB, compounding the lack of clinical distinction in many patients 
[19]. 
We have attempted to clarify the expression of type VII collagen 
within the various subtypes of DEB using pre-embedding immun-
oelectron microscopy, with the aims of establishing a method for 
improving sub-type classification, more accurately defining the na-
ture of the AFs, AF-like structures or thin "wispy fi laments" com-
monly seen below the lamina densa in DEB, and possibly offering 
some insight into the molecular abnormalities that may underlie 
this subgroup of EB patients. 
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Figure 1. Transmission electron microscopy. (A) Normal control, showing numerous cross-banded,. fan~g AFs (arrows) inserting into the lamina 
densa. (B) Dominant DEB; there is some variability in the number of AFs along the dermal-eplder~:nal Junction (compare arrowed. sites). (C) Localized 
recessive DEB; no definite AFs are present but some wisp-like structure~ can be seen below th~ lamma densa (arrows). (D) Generalized recessIVe DEB; a 
few fine fibrillar structures can be seen in both intact and separated skin (arrows) . Magmfication X 22,100; bar, 0.5 )lm. 
MATERIALS AND METHODS 
Patients and Specimens The diagnosis of EB and definition of 
the disease subtype were established on the basis of clinical examina-
tion and family history of trauma-induced blistering, electron mi-
croscopy (5), and indirect immunofluorescence using antibodies to 
type VII collagen [11). type IV collagen,. and GB3 mon~clon~1 
antibody (20). Eleven patients had generalized recessive DEB (SIX 
male, five female; ages 9 - 44 years, mean 23.4 years), five subjects 
had dominant DEB (two male, three female; ages 26- 71 years, 
mean 40.3 years), and there were six cases of localized recessive 
DEB (four male, two female; ages 9 - 64 years, mean 30.0 years). 
The dominant and localized recessive DEB subtypes had some over-
lapping clinical features, but were distinguished on the basi~ of 
patterns of inheritance, although one case of l'resumed 10ca~lzed 
recessive DEB was sporadic. In three of five dommant DEB patients 
the condition was mainly limited to blistering, scarring, and milia 
formation over bony prominences on the extremities and extensor 
surfaces of the limbs. Two cases had more widespread trunk and 
limb involvement. In the localized recessive DEB patients there 
were predominantly acral changes with scarring and milia and o~ly 
occasional blistering. Two of these patients had mild dysphagia. 
Some nail dystrophy was present but this was usually less marked 
than in the dominant DEB cases. The 11 generalized recessive DEB 
patients all had extensive cutaneous and mucous memb:a~e sca.r-
ring, pseudosyndactyly, and flexion contractu res of the digits. Sk111 
samples from 14 healthy control subjects (nine male, five female; 
ages 18 - 72 years, mean 39.0 years), were also studied. Most of the 
specimens were sampled from the thigh to reduce the significance 
of regional variations in anchoring fibril counts (18) . Informed pa-
tient consent was sought for all biopsies and Ethical Committee 
approval was obtained for the study. 
Immunofluorescence Skin samples were snap-frozen in liquid 
nitrogen and processed for indirect immunofluorescence as de-
scribed previously (21). Five-micrometer cryostat sections were in-
cubated at 37"C for 30 min with LH 7:2 antibody diluted 1:1 in 
phosphate-buffered saline/bovine serum albumin. LH 7:2 is a 
~nouse m?noclon~l antibody directed against a 60-kD polypeptide 
m the ammotenl11nus of t~e type Vllc molecule (22) . After washing 
m phosphate-buffer~d sal me, rabbit anti-mouse fluorescein-conju-
gated seco~dary antibody (ICN lmmunobiologicals UK, Ltd.), di-
luted 1 :50 m phosphate-buffered saline/bovine serum albumin, was 
applied for .30 min at 37 °C. After further washing in phosphate-
buffered sal.me, the se~tlOns were mounted in glycerol/phosphate-
buffered salme contal111ng paraphenylenediamine and viewed under 
a. fluorescent microscope. Control incubations using fluorescent an-
tibody alone were also studied. 
Electron Microscopy Small pieces of skin « 2 mm3) were pro-
ce~sed for e1e~tr01: microscopy using standard methods (23) , with 
primary fixatIOn 111 half-strength Karnovsky fixative (containing 
2% formaldehyde and 2.5% glutara ldehyde in 0.04 M cacodylate 
buffer) and secondary fixation in 1.3% osmium tetroxide. The sam-
ples we:e the~ dehydrated in ethanol and embedded in Epon resin. 
Ultratlun sections were stained with uranyl acetate and lead citrate 
and observed in a lEOL 100CX transmission electron microscope. 
Immunoelectron Microscopy Small pieces of skin «2 mm3) 
were washed in phosphate-buffered saline for 1 h at 4°C before 
incubation in the primary antibody. LH 7:2 was diluted 1:1 in 1 % 
bovine serum albumin/l % normal goat serum/ D. 1 % gelatin in 
phosphate-buffered saline (pH 7.4) and incubated overnight at 4°C. 
After washing in phosphate-buffered saline for 6 h at 4°C, the 
specimens were incubated overnight at 4°C in 1 nm gold-conju-
gated goat anti-mouse secondary antibody (Amersham U.K.) di-
luted 1:3 in Tris-buffered saline (pH 8.2). The samples were then 
washed in phosphate-buffered saline for 3 h at 4°C before fixation 
in half-strength Karnovsky fixation (see above) for 4 h at room 
temperature. The skin was then washed briefly in phosphate-buf-
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Figure 2. Electron micrographs of imrnunogold labeling with LH 7:2 antibody. (A) Normal control; labeling is present along the lamina densa and in 
anchoring plaques in association with AFs. (B) Dominant DEB; imrnunolabeling is similar to the normal control, though there is some variability in 
labeling intensity along the dermal-epidermal junction. (C) Localized recessive DEB; many of the ill-defined fibrillar structures have specific immunola-
beling most particularly subjacent to hemidesmosomes. (D) Generalized recessive DEB; scanty labeling can occasionally be found on tangled thin fibrils 
just below the lamina densa in both intact and separated skin. Magnification X 32,000; bar, 0.5 J1.tII. 
fered saline, distilled water, and finally 0.25 M citrate solution. 
Silver en hancement was performed en bloc using a silver-enhance-
ment kit (Amersham U.K.) diluted 1:1 in distilled water for 8-12 
min at room temperature. The reaction was stopped by re-immers-
ing the specimens in the citrate buffer at room temperature. Second-
ary fi xation in osmium tetroxide and subsequent electron micros-
copy processing was then performed as described earlier. Sections 
were cut from the very edge of the tissue block and stained with 
uranyl acetate for 10 min and with lead citrate for 10-20 seconds. 
For control studies, conditioned medium from the parent myeloma 
cell line was used instead of the primary antibody. A semi-quantita-
tive morphometric assessment of type VIlc-labeled fibrillar struc-
tures below the lamina densa was made in one example from each of 
the different subtypes of DEB and a normal control subject. The 
maximal transverse diameter of up to 50 consecutively immunola-
beled "fibrils" was measured by examining overlapping electron 
micrographs (magnification approximately X 50,000) with an eye-
piece graticule (magnification X 10). Measurements were taken 
from the central portion of these fibrils (approximately the middle 
third), and away from the fanning ends. The maximum diameter of 
an immunolabeled structure was measured to the nearest nano-
meter. All prints were Rapidoprints (Agfa-Gevaert, ,Germany) in 
which enlargement stretching has previously been shown to be 
negligible [18]. The precise magnification of the micrographs was 
calculated using a calibration grating (2160 lines/mm). Approxi-
mately 20 11m of continuous lamina densa was analyzed in each 
instance on randomly selected fields. Assessment of the same fields 
by two independent observers GAM, AO'G) showed an inter-ob-
server error of less than 4% in calculating the mean diameter of 
immunolabeled fibrils in each individual subject. 
RESULTS 
Immunofluorescence All the dominant DEB patients had 
bright linear dermal-epidermal junction fluorescence with LH 7:2 
antibody, which was indistinguishable from normal skin. In local-
ized recessive DEB, staining was near-normal in one case and vari-
ably reduced in the other five. Seven of the 11 patients with general-
ized recessive DEB had undetectable immunofluorescent labeling 
with LH 7:2. Skin from the other four subjects, however, had defi-
nite, faint linear dermal-epidermal junction staining that was consid-
erably less bright than the normal controls. The clinical appearances 
of these four patients showed some features akin to the inversa form 
of DEB [10]. with prominent scarring in the major flexures, but the 
degree of generalized blistering and mutilating scarring was very 
similar to the other seven patients with severe generalized recessive 
DEB. All the DEB and normal human skin specimens had similar 
basement membrane zone labeling with GB3 antibody and type IV c 
antiserum. 
Electron Microscopy (Figure 1) In all the dominant DEB 
cases, most of the AFs appeared morphologically normal, although 
some variability in the number of AFs beneath the lamina densa at 
any given point was noted. Additionally, there were some fibrillar 
structures present below the lamina densa that lacked definite cross 
banding or fanning [5 ,18]. In localized recessive DEB, the appear-
ances of "AFs" were quite variable, with samples from different 
patients showing some, little, or no resemblance to normal AFs. 
Numerous thin, wispy sub-lamina densa filaments of uncertain eti-
ology and composition were seen to varying degrees in these pa-
tients. In generalized recessive DEB, no definite AFs as defined by 
Tidman and Eady were seen [5,18]. Beneath the lamina densa some 
thin irregular filamentous structures were noted that were also seen 
in the roof of blistered skin. 
ImmuDoelectroD Microscopy (Figure 2) In dominant DEB, 
LH 7:2 immunolabeling showed a subtle reduction in labeling den-
sity over short sections of the dermal-epidermal junction, although 
most of the immunostaining resembled normal controls, with 
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Figure 3. Immunoelectron micrographs of labeling with L~ 7:2 a~tibody in one patient with localized recessive DEB (sporadic case). Imrnunolabelingis 
present in basal cell endoplasmic reticulum and cytoplasnuc vesIcles (arrows) as well as In assocIatIOn WIth a henudesmosome (arrowhead) and at the 
dermal-epidermal junction. Magnification X 70,400 (A,B) ; X 102,400 (C); bar, 0.25 /lm. 
LH7:2 deposits within the lamina densa and anchoring plaques. 
The immunolabeled structures often resembled normal AFs, but 
labeling was also present on thinner fibrils without cross-banding or 
fanning, and occasionally on grouped, thin, closely approximated 
"horse-tail-like" structures just below the lamina densa. 
In localized recessive DEB, many of the thin wispy sub-lamina 
densa filaments seen on electron microscopy had specific labeling 
with LH 7:2. The labeling was most apparent on tangled fibrillar 
collections just below the lamina densa at sites subjacent to hemi-
desmosomes. There was some labeling of anchoring plaques but this 
was less than in dominant DEB or control specimens. Labeling of 
fibrillar loops, arising from and inserting into the lamina densa, was 
noted in normal control skin and was occasionally seen in dominant 
DEB, but was not found in either localized or generalized recessive 
DEB specimens. Some anti-type VIIc labeling was also seen in domi-
nant J?EB .and localized recessive DEB samples within the endo-
plasmIC reticulum or cytoplasmic vesicles of basal keratinocytes (Fig 
3A,B). Examination of serial ultrathin sections showed that there 
was no direct communication between these areas of labeling and 
the upper dermIs. In these samples, immunolabeling was also seen in 
association with hernidesmosomes {Fig 3C}. Minor disruptions of 
the plasma membrane were seen in many of the samples assessed by 
Figure 4. Immunoelectron micrograph showing labeling with LH 7:2 antibody in a patient with severe generalized recessive DEB, in whom immunoflu-
orescent staining showed faint, but nevertheless positive, linear DE] fluorescence. Scanty sub-lamina densa wisp-like structures show some immunola-
beling, but most of the labeling is present within the lamina densa without any associated " fibrils ." Magnification X45,400; bar, 0.5 /lm. 
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Table I. Maximal Transverse Diameters (nm) of LH 7: 2 - Labeled Fibrils in Individuals with Different Forms of DEB" 
Range Median Mean SO SEM 95% Confidence Interval 
Normal control 10-30 18 
Dominant DEB 10-24 15 
Localized recessive DEB 7-19 13 
Generalized recessive DEB 3-16 11 
• All values expressed in nanometers. 
this pre-embedding immunoelectron microscopy method, but 
overall the ultrastructural morphology was well preserved. 
All 11 patients with generalized recessive DEB had some im-
munoelectron microscopy evidence of type VII collagen expression. 
In the seven patients with negative basement membrane zone LH 
7:2 immunofluorescence, a few fine immunolabeled structures were 
detected beneath the lamina densa subjacent to hemidesmosomes. 
In contrast, the four patients with faintly positive LH 7:2 fluores-
cence also had similar wisp-like labeled structures, but in addition 
immunogold labeling was present within the lamina densa (com-
pare Fig. 2D with Fig 4). This pattern of immunolabeling was also 
focally concentrated subjacent to hemidesmosomes. Very occa-
sional LH 7:2 labeling was also seen within the lamina lucid a below 
hemidesmosomes in all 11 patients with severe recessive DEB. 
There was no significant non-specific background immunolabeling 
in any of the negative control specimens. 
Morphometry ofImmuuolabeled Fibrils Considerable varia-
bility was noted in the measurements of the maximal transverse 
diameter of immunolabeled fibrils even allowing for the fact that 
the methodology involved a two-dimensional assessment of a 
three-dimensional fibrillar network. Immunolabeling was seen on 
fibrils from 3 to 30 nm in diameter. Table I illustrates the observed 
diameters in ra\;domly selected individuals from each group. Al-
though these patients were clinically representative of a particular 
subtype, a direct comparison based on individual data is not necessar-
ily valid and the morphometric data presented is intended to be 
illustrative rather than definitive. Nevertheless, the impression per-
sisted of a reduction in immunolabeled fibril diameter that becomes 
greater with increasing clinical severity. Further assessment of a 
much larger range of DEB patients by this technique will be neces-
sary to see if formal morphometric analysis is able to form the basis 
of more accurate subtype class ification. 
DISCUSSION 
The major component of AFs is type VII collagen, which is predom-
inantly synthesized by keratinocytes [24,25] , with a lesser additional 
contribution from dermal fibroblasts [26], although epithelial-me-
senchymal interactions appear to be important for maximum synthe-
sis [27] . Type VII procollagen consists of a 145-kD central triple 
helix with globular end domains (145 kD and 30 kD) and is approxi-
mately 450 nm in length . In normal human skin, monomers of type 
VIIc assemble to form anti-parallel dimers that then aggregate later-
ally to form anchoring fibrils [28,29]. The gene for type VII colla-
gen (COL7 AI) has recently been partially characterized and 
mapped to the short arm of chromosome 3 [30]. Genetic linkage 
analysis using COL 7 A 1 markers has shown significant linkage in 
Finnish families with dominant forms of DEB [31]. This linkage 
has also been confirmed using an anonymous 3p21 marker in three 
British families with dominant DEB [32]. Primary structural pro-
tein abnormalities of type VIIc would therefore appear to be present 
in dominant DEB. An inability to correctly form normal aggre-
gated, anti-parallel, triple helical type VIIc dimers in patients with 
dominant DEB was supported in the present immunoelectron mi-
croscopy study by the findings of thin fibrils with limited cross-
banding and fanning that still labeled for the globular region of type 
VIle. The reduction in transverse diameter of many of the immuno-
labeled fibrils would be in keeping with a structural abnormality in 
type VIIc. Likewise, the "horse-tail" morphology of certain im-
munolabeled fibrils seen in some patients with dominant DEB 
17.7 3.68 0.52 16.68-18.72 
14.9 3.30 0.47 13.97 - 15.82 
13.2 2.86 0.41 12.39-14.00 
10.7 3.52 0.83 8.96-12.44 
could represent an impairment oflateral aggregation of anti-parallel 
dimers secondary to an underlying type VIIc gene mutation (Fig 5) . 
Primary inherited structural defects of type VIIc may also be 
implicated in recessive DEB patients, although other abnormalities 
of type VIIc synthesis, secretion, polymerization, breakdown, or a 
combination of two or more of these processes may be involved 
[33-36]. Early genetic linkage studies have also suggested 
COL7 Al as the candidate gene in recessive DEB [37] , although 
further genetic abnormalities involving other basement membrane 
proteins could account for an additional lamina lucida defect in 
some subtypes [38,39]. A further controversy is the presence or 
absence of type VIIc in severe generalized mutilating forms of re-
cessive DEB. Some studies, involving immunofluorescence, im-
munoelectron microscopy, and immunoblotting, have shown a 
complete absence of type VIIc [12,13], whereas some type VIIc 
expression has been noted in the skin of such patients using a puri-
fied concentrated anti-type VIIc antibody [14) or as a transient phe-
nomenon during would healing [40]. In this study there was some 
evidence of type VII collagen expression at the dermal-epidermal 
junction in all patients with recessive DEB, either in the form of 
scanty wisp-like fibrils beneath the lamina densa or with findings of 
additional non-fibril-associated labeling within the lamina densa. 
These immunoelectron microscopy findings suggest that a similar 
severe phenotype may result from more than one type VIlc gene 
abnormality affecting the expression or structure of type VII colla-
gen. Cases of completely absent type VIIc could still theoretically 
arise if transcription of the gene was affected, but there was no 
evidence for this in the present study. 
In milder forms oflocalized recessive DEB there was an increased 
amount of sub-hemidesmosomal immunolabeled fibrils and lamina 
densa labeling that, on the relatively small number of cases studied, 
appeared to have some inverse correlation with the degree of clini-
cal severity. The tangled appearances of these immunolabeled fibrils 
would be in keeping with a range of underlying type VII collagen 
gene abnormalities affecting the structural integrity of the anchor-
ing fibrils. The finding of conserved globular region immunolabel-
ing on structurally defective AFs has also been recently noted in a 
patient with the inversa form of DEB [41), although the precise 
genetic, clinical and laboratory diagnostic characteristics of this par-
ticular subtype of DEB have not been universally defined [10) . 
The observation of intracellular type VIlc within the endoplas-
mic reticulum and cytoplasmic vesicles of basal cells in some cases of 
localized recessive DEB and dominant DEB is interesting. Labeling 
of intracellular epitopes is not usually possible using pre-embedding 
immunoelectron microscopy, but examination of the dermal-epi-
dermal junction in this study showed several minor disruptions of 
the cell plasma membrane. Thus, permeabilization of basal cells was 
felt to be the mechanism that allowed intracellular type VII collagen 
immunolabeling, rather than an alternative explanation of interna-
lization and vesicle transport. This interpretation is supported by 
other studies in which we used a similar pre-embedding technique 
in conjunction with anti-keratin antibodies, and observed labeling 
of keratin intermediate filaments in the lower parts of basal epider-
mal cells (Ishida-Yamamoto et ai, unpublished). Intracellular type 
VIlc labeling is known to occur in cases of transient bullous dermo-
lysis of the newborn, in which there are clinical features of DEB that 
usually, but not invariably, resolve within a few months [42]. It has 
also been re.rorted in a case of probable recessive DEB that died at 
age 10 d [43J. However, these cases have often been associated with 
ultrastructurally distinct peri-nuclear "stellate bodies" that were not 
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NORMAL HUMAN SKIN 
DOMINANT DYSTROPHIC EB 
LOCALIZED RECESSIVE 
DYSTROPHIC EB 
GENERALIZED RECESSIVE 
DYSTROPHIC EB 
Figure 5. Diagrammatic representation of the differing morphology of 
fibrillar structures at the dermal-epidermal junction immunolabeled by 
LH 7:2 antibody in normal skin and in the various subtypes of DEB; see 
text for details. 
seen in the present DEB cases. The findings in our cases of DEB 
might be explained by post-translational modification of structur-
ally abnormal type VIIc such as over-hydroxylation, which then 
impairs secretion from the basal keratinocyte to the dermal-epi~er­
mal junction. The intracellular labeling was also seen overlymg 
hemidesmosomes. Although the precise role ofhemidesmosomes in 
cell adhesion and cell membrane transport is not well established, 
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the immunoelectron microscopy findings would be in keeping with 
hernidesmosomes possibly acting as "release points" for the type 
VIIc. However, this interpretation remains speculative until more is 
known about the normal m ech anisms and pathways involved in the 
secretion of type VIIc by keratinocytes. 
Many of the fibrillar structures beneath the lamina densa in the 
various subtypes of DEB did not label with the type VIIc antibody. 
This may be due to cross-sectioning of the AFs, incomplete epitope 
labeling, non-recognition of some anchoring fibril epitopes, or the 
"fibrils" being composed of proteins o ther than those associated 
with AFs . The possibility of other microfibrill ar components such 
.as type VI collagen [44] or fibrillin [45] contributing to these struc-
tures h as still to be assessed. 
Although molecular biologic studies will be fundamental to 
characterizing a probable multiplicity of type VIIc gene abnormali-
ties in DEB, there remains the practical problem of separating over-
lapping clinical features and a lack of precise subtype distinction on 
electron microscopy and immunofluorescence in the different 
forms of DEB. This pre-embedding immulloelectron microscopy 
technique should be useful in this regard, and the application of 
other type VIIc or AF-associated antibodies m ay give some clear 
indication of AF dysfuIlction in DEB. 
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